Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
10/15/2024
China Expands Health Silk Road to Dominate Africa's Pharmaceutical Mar...
10/15/2024
Eli Lilly Invests $200M to Expand Chinese Manufacturing Facility for D...
10/15/2024
Akeso Secures $250M to Propel Global Expansion of Its Innovative Drug...
10/15/2024
Wuhan iRegene Completes Over CNY 100M Series B Financing
10/15/2024
AstraZeneca/Daiichi's Enhertu Approved in China as First HER2-directed...
10/11/2024
CanSino Receives Over $17M from Gates Foundation to Accelerate Polio V...
10/11/2024
Japan Strengthens Pharmaceutical Supply Chain to Reduce Dependence on ...
10/11/2024
InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-488 Me...
10/10/2024
Bio-Thera Secures $110M Drug Licensing Deal with Hungary's Gedeon Rich...
10/10/2024
Guangdong Aims to Boost Biopharma Sector to Over CNY 1 Trillion by 202...
10/10/2024
Eli Lilly Submits Chinese NDA for Its Anti-IL23 Antibody Mirikizumab
10/10/2024
Nona Biosciences Enters Strategic Collaboration with OverT Bio to Adva...
10/10/2024
QuantumPharma's Subsidiary Ailux Biologics Partners with Janssen Biote...
10/9/2024
US Venture Capital Opens Funding Opportunities for China Biotech Firms
10/9/2024
Bayer Launches Life Sciences Incubator in Shanghai
10/8/2024
China Grants Conditional Approval to Biogen's ALS Therapy Qalsody
10/8/2024
AstraZeneca Expanding R&D pipeline in China
10/8/2024
CSPC Announces Regulatory Milestones in China and the U.S.
10/8/2024
BeiGene Launches Tevimbra in US, Enters Competitive PD-1 Inhibitor Mar...
10/8/2024
Wuhan YZY Biopharma and CT Tianqing Enter Exclusive License Agreement ...
10/8/2024
Wuhan YZY Biopharma and CT Tianqing Enter Exclusive License Agreement ...
10/8/2024
Zephyrm Bioscience Files for IPO on HKSE with CICC as Sponsor
10/8/2024
Genor Biopharma to Merge with Eddingpharm in Strategic Reverse Takeove...
10/8/2024
Innovent and Ask Pharm Enter Strategic Deal for Limertinib
10/8/2024
AstraZeneca gains rights to CSPC's lipid-lowering therapy in deal wort...
10/8/2024
MediLink and Amgen Enter Global Clinical Trial Deal on YL201 Combinat...
10/3/2024
Domestic Pharma Companies Saw Rapid Growth in Outlicensing Deals in 20...
10/3/2024
WuXi Considers Asset Sales Amid BIOSECURE Scrutiny: FT
10/1/2024
AFT in China License Deal with Xizang Weixinkang Pharma for Maxigesic ...
10/1/2024
Haleon Plans to Raise Stake in Chinese JV to 88%
Page:
17
/
23
Total number of articles:
663
:
[First]
[<<]
[15]
[16]
[17]
[18]
[19]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit